Article

IntraLase sales, volume continue to rise

Irvine, CA-IntraLase Corp. sold 30 lasers during its second quarter ended June 30, bringing the total number of its lasers to 153 units globally.

Irvine, CA-IntraLase Corp. sold 30 lasers during its second quarter ended June 30, bringing the total number of its lasers to 153 units globally.

More than 48,000 procedures were performed with the lasers during the second quarter, representing an increase of about 150% compared with the same period last year.

According to the company, MarketScope reports that IntraLase's laser-created flaps accounted for about 14% of all LASIK procedures performed during the second quarter, up from 12% during the first quarter of the year.

Haffey was the vice president of business development and a member of the executive management team. He will lead the new commercial operation, which houses sales, marketing, customer and technical support, and field service.

Devnew was a regional sales manager. He will now be responsible for managing key corporate accounts.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.